US HIV Aid at a Tipping Point as Funding Cliff Looms

Millions relying on US-funded HIV/AIDS programs face an uncertain future as a funding cliff nears: 120 CDC-backed PEPFAR awards expire with no clear replacement, potentially disrupting testing, treatment, PrEP and lab services for more than 8.7 million patients worldwide, especially in Mozambique, Tanzania and South Africa; the State Department’s restructuring could shift control away from CDC, prompting concerns among health experts that services and surveillance could suffer even as officials promise continuity and increased funding in other areas.